China NMPA Product Recall - Smart blood pressure monitor

On December 14, 2018, the National Medical Products Administration (NMPA) announced that Shandong Zhonghong Information Technology Co., Ltd. initiated a voluntary Class III recall for specific batches of its Smart Blood Pressure Monitor. This action was prompted by a critical labeling deficiency: the outer packaging of the affected devices lacked essential information regarding the "cuff application scope." The recall primarily targets Smart Blood Pressure Monitors with batch numbers 201706001 and 20162200498. While the document does not detail specific inspection dates, the recall announcement from the NMPA serves as the official public notification of this compliance issue. The regulatory framework under which this recall occurred is overseen by the NMPA, which is responsible for safeguarding public health by regulating medical devices in China. Shandong Zhonghong Information Technology Co., Ltd. is required to undertake comprehensive recall measures as detailed in their "Medical Device Recall Event Report Form." This proactive, voluntary recall by the manufacturer highlights their commitment to addressing product non-conformities and ensuring patient safety, aligning with NMPA's regulatory standards for medical device labeling and quality. The Level III classification indicates that the non-conformity is unlikely to cause adverse health consequences, but correction is still necessary to maintain product integrity and regulatory compliance.